Pulmonary embolism in the pregnant patient

Jump to navigation Jump to search

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism in the pregnant patient On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism in the pregnant patient

CDC on Pulmonary embolism in the pregnant patient

Pulmonary embolism in the pregnant patient in the news

Blogs on Pulmonary embolism in the pregnant patient

Directions to Hospitals Treating Pulmonary embolism in the pregnant patient

Risk calculators and risk factors for Pulmonary embolism in the pregnant patient

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

jhdslkjhfkjfah[1]

References

  1. Derks M, Oudijk MA, van der Made F, van den Born BJ, van der Post JA (2011). "[Catastrophic antiphospholipid syndrome during pregnancy]". Ned Tijdschr Geneeskd. 155 (18): A3263. PMID 21771361.

Template:WH Template:WS